| Nicotine as a potential neuroprotective agent for Parkinson's disease M Quik, XA Perez, T Bordia Movement disorders 27 (8), 947-957, 2012 | 287 | 2012 |
| An evaluation of garlic and onion as antithrombotic agents T Bordia, N Mohammed, M Thomson, M Ali Prostaglandins, leukotrienes and essential fatty acids 54 (3), 183-186, 1996 | 186 | 1996 |
| Multiple roles for nicotine in Parkinson's disease M Quik, LZ Huang, N Parameswaran, T Bordia, C Campos, XA Perez Biochemical pharmacology 78 (7), 677-685, 2009 | 182 | 2009 |
| Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation M Ali, T Bordia, T Mustafa Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 60 (1), 43-47, 1999 | 153 | 1999 |
| Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates M Quik, N Parameswaran, SE McCallum, T Bordia, S Bao, A McCormack, ... Journal of neurochemistry 98 (6), 1866-1875, 2006 | 148 | 2006 |
| Continuous and intermittent nicotine treatment reduces L-3, 4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease T Bordia, C Campos, L Huang, M Quik Journal of Pharmacology and Experimental Therapeutics 327 (1), 239-247, 2008 | 136 | 2008 |
| Nicotinic receptors as CNS targets for Parkinson's disease M Quik, T Bordia, K O’Leary Biochemical pharmacology 74 (8), 1224-1234, 2007 | 129 | 2007 |
| Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides M Thomson, KK Al-Qattan, T Bordia, M Ali The Journal of nutrition 136 (3), 800S-802S, 2006 | 128 | 2006 |
| Nigrostriatal damage preferentially decreases a subpopulation of α6β2* nAChRs in mouse, monkey, and Parkinson's disease striatum T Bordia, SR Grady, JM McIntosh, M Quik Molecular pharmacology 72 (1), 52-61, 2007 | 121 | 2007 |
| Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease M Quik, D Zhang, M McGregor, T Bordia Biochemical pharmacology 97 (4), 399-407, 2015 | 120 | 2015 |
| Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6 (nonα4) β2* nAChR expression and function XA Perez, T Bordia, JM McIntosh, SR Grady, M Quik Molecular pharmacology 74 (3), 844-853, 2008 | 94 | 2008 |
| Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine or L-DOPA M Quik, S Vailati, T Bordia, JM Kulak, H Fan, JM McIntosh, F Clementi, ... Molecular pharmacology 67 (1), 32-41, 2005 | 94 | 2005 |
| Histopathological effects of garlic on liver and lung of rats MA Alnaqeeb, M Thomson, T Bordia, M Ali Toxicology letters 85 (3), 157-164, 1996 | 92 | 1996 |
| Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys LZ Huang, N Parameswaran, T Bordia, J Michael McIntosh, M Quik Journal of neurochemistry 109 (3), 826-837, 2009 | 91 | 2009 |
| Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization T Bordia, C Campos, JM McIntosh, M Quik Journal of Pharmacology and Experimental Therapeutics 333 (3), 929-938, 2010 | 90 | 2010 |
| Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias T Bordia, XA Perez, JE Heiss, D Zhang, M Quik Neurobiology of disease 91, 47-58, 2016 | 86 | 2016 |
| Loss of α‐conotoxinMII‐and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum M Quik, T Bordia, L Forno, JM McIntosh Journal of neurochemistry 88 (3), 668-679, 2004 | 82 | 2004 |
| Nicotine and nicotinic receptor drugs: potential for Parkinson's disease and drug-induced movement disorders M Quik, T Bordia, D Zhang, XA Perez International review of neurobiology 124, 247-271, 2015 | 81 | 2015 |
| Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum T Bordia, M Hrachova, M Chin, JM McIntosh, M Quik Journal of Pharmacology and Experimental Therapeutics 342 (2), 327-334, 2012 | 80 | 2012 |
| Role for the nicotinic cholinergic system in movement disorders; therapeutic implications M Quik, D Zhang, XA Perez, T Bordia Pharmacology & therapeutics 144 (1), 50-59, 2014 | 75 | 2014 |
